BackFuji Pharma , Ltd. Overview

Fuji Pharma , Ltd. Receivables

Fuji Pharma , Ltd.'s receivables is $20B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$19.88B
↑ 14.12% YoYΔ $2.46B vs prior year quarter

Peer trimmed avg / median

Loading

Fuji Pharma , Ltd. Receivables History

Loading

Fuji Pharma , Ltd. vs. peers: Receivables Comparison

Loading

Fuji Pharma , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Fuji Pharma , Ltd. (4554.T) FAQ

As of the most recent data (June 2026), 4554.T shows a receivables of $20B. That compares with $17B in the prior-year period — up 14.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4554.T's receivables is now $20B (was $17B) — a 14.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fuji Pharma , Ltd. is outperforming or lagging.

Tracking 4554.T's receivables over time shows whether Fuji Pharma , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $20B That compares with $17B in the prior-year period — up 14.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Fuji Pharma , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $20B) with ownership activity and broader fundamentals.